DDAVP treatment combined with FVIII clotting factor concentrates in patients with mild haemophilia A.

Trial Profile

DDAVP treatment combined with FVIII clotting factor concentrates in patients with mild haemophilia A.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 20 Jun 2016

At a glance

  • Drugs Desmopressin (Primary) ; Moroctocog alfa (Primary) ; Octocog alfa (Primary) ; Rurioctocog alfa (Primary) ; Turoctocog alfa (Primary)
  • Indications Haemophilia A
  • Focus Therapeutic Use
  • Acronyms DAVID
  • Most Recent Events

    • 20 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top